Related references
Note: Only part of the references are listed.General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC
Sandra-Annika Quast et al.
PLOS ONE (2012)
Loss of Estrogen Receptor 1 Enhances Cervical Cancer Invasion
Yali Zhai et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
17-DMAG targets the nuclear factor-κB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
Erin Hertlein et al.
BLOOD (2010)
Insulin/IGF-1 paradox of aging: Regulation via AKT/IKK/NF-κB signaling
Antero Salminen et al.
CELLULAR SIGNALLING (2010)
An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes
Christian Freise et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
NF-κB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy
Jian-Min Wu et al.
CANCER LETTERS (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells
Bryan C. Fuchs et al.
CANCER RESEARCH (2008)
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease
Diego F. Calvisi et al.
CARCINOGENESIS (2008)
Clotrimazole Ameliorates Intestinal Inflammation and Abnormal Angiogenesis by Inhibiting Interleukin-8 Expression through a Nuclear Factor-κB-Dependent Manner
Dinesh Thapa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
NF-kappa B signaling, liver disease and hepatoprotective agents
B. Sun et al.
ONCOGENE (2008)
Blockage of intermediate-conductance-Ca2+-activated K+ channels inhibits progression of human endometrial cancer
Z. H. Wang et al.
ONCOGENE (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Genomics and signaling pathways in hepatocellular carcinoma
Augusto Villanueva et al.
SEMINARS IN LIVER DISEASE (2007)
The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration
Vikas Kaushal et al.
JOURNAL OF NEUROSCIENCE (2007)
Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer
H Dalwadi et al.
CLINICAL CANCER RESEARCH (2005)
Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo
I Grgic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro
H Jäger et al.
MOLECULAR PHARMACOLOGY (2004)
Ether a go-go potassium channels as human cervical cancer markers
LMB Farias et al.
CANCER RESEARCH (2004)
Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines:: electrophysiological, pharmacological and molecular characterisation
SP Fraser et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2003)
Effects of intermediate-conductance Ca2+ activated K+-channel modulators on human prostate cancer cell proliferation
AS Parihar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
KV1.1 K+ channels identification in human breast carcinoma cells:: Involvement in cell proliferation
H Ouadid-Ahidouch et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1:: A potential immunosuppressant
H Wulff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Differentiation status modulates transcription factor NF-κB activity in unstimulated human hepatocellular carcinoma cell lines
TZ Liu et al.
CANCER LETTERS (2000)
Share Paper
